Patient Retrospective Outcomes (PRO)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15,000
- 试验地点
- 278
- 主要终点
- Responder rate
研究概览
简要总结
This study will evaluate de-identified (anonymous) data in subject medical charts to review the clinical outcomes of various treatment approaches in the treatment of chronic pain.
详细描述
This study is a retrospective, multi-center, de-identified patient data review.
The study will include multiple independent cohorts to evaluate clinical outcomes in different subgroups.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Previously treated with or eligible for use with Boston Scientific Systems
- •18 years of age or older at the start of Baseline
排除标准
- 未提供
研究组 & 干预措施
Patients eligible for SCS, RF or other treatment approaches
Patients who have previously been implanted with, or are eligible for implantation with a spinal cord stimulation system or various other treatment approaches such as RF, IDS, etc.
干预措施: Boston Scientific Systems (Device)
Patients Eligible for treatment options with prior treatment
Patients who have previously been implanted with a spinal cord stimulation system or other various treatments, and have thereafter received a different form of chronic pain treatment such as a different SCS system, RF, IDS etc.
干预措施: Non Boston Scientific Systems (Device)
Patients eligible for SCS, RF or other treatment approaches
Patients who have previously been implanted with, or are eligible for implantation with a spinal cord stimulation system or various other treatment approaches such as RF, IDS, etc.
干预措施: Non Boston Scientific Systems (Device)
Patients Eligible for treatment options with prior treatment
Patients who have previously been implanted with a spinal cord stimulation system or other various treatments, and have thereafter received a different form of chronic pain treatment such as a different SCS system, RF, IDS etc.
干预措施: Boston Scientific Systems (Device)
结局指标
主要结局
Responder rate
时间窗: Through study completion, approximately two years
Responder rate for pain relief through study completion.
次要结局
未报告次要终点